Dov A Md Goldstein
CFO at BioAge Labs, Inc. (BIOA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $532K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 15SEC | BIOABioAge Labs, Inc. | Sell Plan | 8,97440,434 held (−18%) | $18.43 | $165K | -73.7% |
| Jan 15SEC | BIOABioAge Labs, Inc. | Sell Plan | 4,44035,994 held (−11%) | $19.45 | $86K | -75.1% |
| Jan 15SEC | BIOABioAge Labs, Inc. | Sell Plan | 11,66324,331 held (−32%) | $20.54 | $240K | -76.4% |
| Jan 15SEC | BIOABioAge Labs, Inc. | Sell Plan | 1,92322,408 held (−8%) | $21.08 | $41K | -77.0% |
- Sell
CFO Dov A Md Goldstein sold $165K of BIOA at $18.43 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Dov A Md Goldstein sold $86K of BIOA at $19.45 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Dov A Md Goldstein sold $240K of BIOA at $20.54 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
CFO Dov A Md Goldstein sold $41K of BIOA at $21.08 — pre-scheduled 10b5-1 plan sale.